{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:06 23:25:58.836",
            "Expression": "mesenchymal XCEL-MT-OSTEO-ALPHA",
            "NStudiesAvail": 430108,
            "NStudiesFound": 3,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 3,
            "FieldList": [
                  "ResultsFirstSubmitDate",
                  "ResultsFirstSubmitQCDate",
                  "RetractionPMID",
                  "RetractionSource",
                  "SamplingMethod",
                  "SecondaryId",
                  "SecondaryIdDomain",
                  "SecondaryIdLink",
                  "SecondaryIdType",
                  "SecondaryOutcomeDescription",
                  "SecondaryOutcomeMeasure",
                  "SecondaryOutcomeTimeFrame",
                  "SeeAlsoLinkLabel",
                  "SeeAlsoLinkURL",
                  "SeriousEventAssessmentType",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [
                              "2013-005025-23"
                        ],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [
                              "EudraCT Number"
                        ],
                        "SecondaryOutcomeDescription": [
                              "Safety will be assessed by collecting adverse events throughout the experimental phase which includes a follow-up of 12 month.",
                              "Characteristics of the callus by tomography and Characteristics of the callus by standard x-ray in both treatment arms",
                              "Quality of life will be measured by EUROQOL-5D test"
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Safety assessment of XCEL-MT-OSTEO-ALPHA in non-union fractures",
                              "Efficacy assessment of XCEL-MT-OSTEO-ALPHA in non-union fractures by imaging procedures",
                              "Efficacy assessment by quality of life test"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "12 month",
                              "6 month",
                              "12 month"
                        ],
                        "SeeAlsoLinkLabel": [
                              "Banc de Sang i Teixits (Blood and Tissue Bank of Catalonia)",
                              "Hospital ASEPEYO Sant Cugat"
                        ],
                        "SeeAlsoLinkURL": [
                              "http://www.bancsang.net/",
                              "http://www.asepeyo.es/hospital-sant-cugat"
                        ],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT02230514"
                        ]
                  },
                  {
                        "Rank": 2,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [
                              "2010-023998-18"
                        ],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [
                              "EudraCT Number"
                        ],
                        "SecondaryOutcomeDescription": [
                              "The necrotic angle will be measured using imaging procedures (magnetic resonance imaging MRI).",
                              "Dynamic changes of signal intensity after Gd enhancement in the necrotic areas of the femoral head",
                              "Pain measurement by VAS",
                              "This clinical outcome will measure the quality of life by the self-reported quality of life questionnaire SF-36",
                              "To assess the extent by which a person's functional level is restricted by the WOMAC index"
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Bone regeneration by measuring the necrotic angle using the modified Kerboul method",
                              "Dynamic changes of signal intensity",
                              "Clinical outcomes (pain) by Visual Analogue Scale (VAS)",
                              "Clinical outcomes (SF-36)",
                              "Clinical outcome (WOMAC)"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "6 and 12 months",
                              "6 and 12 months",
                              "7 days and at 3, 6 and 12 months",
                              "3, 6 and 12 months",
                              "3, 6 and 12 months"
                        ],
                        "SeeAlsoLinkLabel": [
                              "Banc de Sang i Teixits. Xcelia-Divisi\u00f3n de Terapias Avanzadas.",
                              "Hospital Universitari Vall d'Hebron, Barcelona"
                        ],
                        "SeeAlsoLinkURL": [
                              "http://www.bancsang.net/",
                              "http://www.vhebron.net/"
                        ],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT01605383"
                        ]
                  },
                  {
                        "Rank": 3,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "Spinal fusion will be assessed by spinal X-Ray",
                              "Spinal fusion will be assessed by the presence of solid bonny bridges using computerized helicoidal tomography.",
                              "Pain measurement by visual analogue scale (VAS)",
                              "This clinical outcome will measure the quality of life by the self-reported quality of life questionnaire SF-36",
                              "To assess the extent by which a person's functional level is restricted by disability by the Oswestry Disability Index"
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Efficacy spinal fusion by imaging procedures (X-Ray).",
                              "Efficacy spinal fusion by imaging procedures (computerized helicoidal tomography)",
                              "Clinical outcomes (VAS)",
                              "Clinical outcomes (SF-36)",
                              "Clinical outcome (Oswestry Disability Index)"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "3, 6 and 12 months",
                              "6 and 12 months",
                              "7 days and at 3, 6 and 12 months",
                              "3, 6 and 12 months",
                              "3, 6 and 12 months"
                        ],
                        "SeeAlsoLinkLabel": [
                              "Banc de Sang i Teixits. Xcelia, Divisi\u00f3n de Terapias Avanzadas.",
                              "Institut Catal\u00e0 de Traumatologia i Medicina de l'Esport (Institut Universitari Dexeus)",
                              "Hospital Universitari Vall d'Hebron, Barcelona",
                              "Hospital Universitari Germans Trias i Pujol, Badalona",
                              "Hospital Parc de Salut Mar, Barcelona",
                              "Hospital de la Santa Creu i Sant Pau, Barcelona"
                        ],
                        "SeeAlsoLinkURL": [
                              "http://www.bancsang.net",
                              "http://www.icatme.com",
                              "http://www.vhebron.net",
                              "http://www.gencat.cat/ics/germanstrias/",
                              "http://www.parcdesalutmar.cat",
                              "http://www.santpau.es/"
                        ],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT01552707"
                        ]
                  }
            ]
      }
}